ACIS is the autonomous public agency attached to the Ministry of Health that responds to the need to manage training in the public health system of Galicia, to promote research in health institutions, to promote and coordinate innovation in the health sector and to evaluate health technologies, processes and services. ACIS is the nucleating element of the ecosystem of knowledge and innovation in health in Galicia.

BIAL is an innovative pharmaceutical company with products available in more than 55 countries. Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. The company is committed to improve human health and quality of life for people from all over the world. Its strategic areas are Innovation, Internationalisation and Quality. The company headquarters are located in Portugal. BIAL has also affiliates in Spain, Germany, United Kingdom, Italy, Switzerland, Mozambique, Angola, Ivory Coast and Panama. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. BIAL has launched eslicarbazepine acetate, an epilepsy drug, already available in the US and in several European countries. BIAL has also developed a Parkinson’s disease compound, opicapone, also commercialized in Europe. The company expects to introduce more new medicines to the market over the next few years, strengthening its international presence based in its own innovative medicines and accomplishing the purpose of delivering innovative products to patients worldwide. BIAL Group is a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA).

Bioga y la Axencia Galega de Innovación organizan el próximo 15 de marzo en el Edificio Emprendia (Santiago de Compostela) el Bioalmorzo Blockchain “Casos de uso en biotecnología” en colaboración con la Asociación Galega Blockchain e IoT (AGALBIT). La jornada dará comienzo a las 10h.Para ello, contaremos con la participación de: Antonino Comesaña: Vicepresidente AGALBIT. Asociación Galega Blockchain e IoT (Ver CV).Pablo López: Asesor Business AGALBIT. Director Creativigo Consultores de Innovación (Ver CV).AGALBIT es una asociación sin ánimo de lucro que tiene como objetivo la divulgación de la tecnología Blockchain o Internet de la Cosas (IoT), así como cualquier sistema de computación descentralizado a particulares, empresas e instituciones.Blockchain junto con otras tecnologías como (IOT, Big Data, IA…) van a cambiar los modelos de negocios y ofrecer grandes oportunidades. En este encuentro hablaremos sobre qué es el blockchain, cómo está evolucionando y cómo puede ser de utilidad para sector biotecnológico.Expondremos casos de uso para reflexionar sobre ellos y exploraremos posibilidades reales para los asistentes (identidad digital, trazabilidad, registro y custodia de datos, smart contracts, tokenización). El objetivo del bioalmorzo es que los asistentes comprendan, de una forma práctica y sencilla qué es Blockchain, en que fase de desarrollo se encuentra actualmente y como puede ser aplicado en las empresas biotech.La asistencia es gratuita.Las personas que deseen asistir pueden inscribirse en la siguiente dirección de correo: julio@bioga.org antes del 14 de marzo.

The Portuguese Catholic University - UCP was created in 1967. Being a non-state entity, it enjoys a high degree of autonomy in the creation and operation of its units, facilities and courses. The UCP comprises 15 Faculties, Schools and Institutes that constitute the teaching and research units located in four regional centers (Braga, Porto, Beiras and Lisbon). In each of these Centers, transversal and complementary competences are identified in various fields of life and health sciences and technologies. The multi- and interdisciplinary nature of health research that is developed in the UCP is based mainly on postgraduate quality training, internationalization and establishing strong links with the industry sector. In this way, the UCP intends to intervene in a significant way in the scientific, economic and social communities through the development of R&D activities in areas ranging from biotechnology (food, environment and biomedical) to health care and aging, exploring current societal challenges for health promotion and well-being.

"From pipelines to market: accelerating innovation and creating value through public-private partnerships and procurement"

23 animal maintenance rooms for house mouse, rat, guineapigs, rabbits, fish, etc. Conventional environment or specific pathogen-free conditions. Technical team: four animal caretakers, one technical assistant, and one veterinary. Anesthesia, Analgesia, Surgery Support and Recover. Tolerances: insulin and glucose. Blood collection. Measuring pressures. Genotyping. Monitoring of animal weights, dietary intake and water intake. Parenteral administrations. Mating, weaning and sexing. Equipment: Autoclave, Ventilated cage racks, Metabolic cages, Luximeter, Hotte.

Microscopy and imagiology advanced studies on cells and tissues. Optical and transmission electronic microscopy sample preparation. Cellular culture techniques, tissue cut and immonocytochemistry. Equipment: “in vivo” imaging station Carl Zeiss Axio Observer. Microscope Zeiss Axioimager Z2- Apotome.  Transmission electronic microscope Jeol. Microm and Leica cryostats. Freezing and parafyn microtome. “Vibratome” Leica.  Ultramicrotome Reichert.

We are a Data and Insights Driven Healthcare ICT Company, focused on helping professionals, managers and patients make better and faster decisions based on the data that already exists. Value based healthcare and artificial intelligence in healthcare are our prime focal points and goals.

Logistical, operational and consulting services in the context of biomedical research projects, as well as custom molecular biology laboratory services, mutant and transgenic mouse models production, and scientific training. Available for groups which have biological material and/or relevant clinical data but due to a lack of available time or experience in laboratory research require support in conceiving and designing a research project. Gene expression studies. Molecular cloning (recombinant DNA techniques). DNA-protein interactions. Genotyping. Molecular Typing. Molecular Biology - Proteomics. Protein expression studies. Protein-protein interactions. Protein separation by two-dimensional electrophoresis. Tagged protein purification (including liquid chromatography). Production of Mutant Animals / Genetic manipulation of the mouse (knock-out, knock-in, deletion). CRISPR/Cas9 and homologous recombination – mediated mutagenesis. Pronuclear Injection. ES cell Injection. Mouse Line Rederivation. Embryo Cryopreservation. Sperm Cryopreservation. In-Vitro Fertilization. Vasectomy and other Surgical Procedures. Bright field microscopy with image aquisition. Fluorescence Microscopy: live cell / embryo imaging; time-lapse; ApoTome optical sectioning; confocal microscopy. Equipment: Bio-Rad Protean i12 IEF Cell; Bio-Rad Trans-Blot Turbo system; Bio-Rad Biologic LP system + BioFrac Fraction collector. Molecular Dynamics Storm 860. MilliPore Milli-Q Integral 3. Thermo Scientific NanoDrop 2000. Agilent Byoanalizer 2100. Real-time PCR. Bio-Rad T100 Thermal. Polytron PT2500E. Thermo Scientific Savant SPD121P-230V SpeedVac concentrator. Thermo Micron HM560. Roche MagNA lyser. Sutter P-97 Micropipette Puller. Bio-Rad ChemiDoc MP. Leica AM6000 automated motorized inverted microscope + TransferMan NK2 Automated Micromanipulators and Microinjectors.